A hot antibody discovery team in China has signed its second US biotech deal in less than six months, marking the latest sign ...

Sanofi is teaming up with a private biotech in Delaware on a pair of bispecific antibodies for autoimmune and inflammatory ...

Walgreens to go private via Sycamore Partners deal at $11.45/share after talks began in Feb 2024. Deal impacted by $595M ...

Jacob Elkins has left Sarepta to take the CMO job at AIRNA, the RNA editing shop that disclosed a $155 million Series ...

The UK on Thursday authorized GSK’s Blenrep to treat certain multiple myeloma patients in two different regimens, marking the ...

The 340B drug discount program may move under the purview of CMS, according to a leaked HHS restructuring document reviewed ...

Roche is stopping patients on the low dose of its experimental Huntington’s drug tominersen, and will be transitioning them ...

The Dutch government is committing €1.3 billion ($1.5 billion) to support biotech as part of a broader raft of measures ...

Bayer opens $44M expansion, Meribel Pharma launches, Ginkgo gets $29M contract, plus partnerships for Chime, Atelerix, ...

Glycomine raises $115M Series C to advance GLM101, a mannose-1-phosphate therapy for PMM2-CDG rare disease, toward Phase 2b ...

Trump's drug pricing EO includes wins on pill penalty reform, faster approvals, and PBM rules, but adds scrutiny on pricing ...

US brand-name drugs use foreign ingredients, with Europe supplying 43% of APIs, as Trump administration considers 25% tariffs ...